2013
DOI: 10.1016/j.braindev.2012.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic epilepsy: An update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
39
0
4

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 41 publications
(43 citation statements)
references
References 78 publications
0
39
0
4
Order By: Relevance
“…An IEM should be suspected in a neonate presenting with seizures, particularly if unexplained and refractory [6]. Moreover, several metabolic disorders present with specific epileptic encephalopathies associated to quite suggestive EEG patterns [8]. Early Myoclonic Encephalopathy (EME) is one of the most severe, drug-resistant epilepsy with poor prognosis Abbreviations NS : neonatal seizures; CNS: central nervous system; IEM: inborn errors of metabolism; EEG: electroencephalogram; EME: early myoclonic encephalopathy; NKH: non-ketotic hyperglycinaemia; HIE: hypoxic-ischemic encephalopathy; UCDs: urea cycle disorders; CPSI: carbamyl phosphate synthetase I; OTC: ornithine transcarbamylase; ASS: arginine succinic acid synthetase; ASL: arginine succinic acid lyase: ARG: arginase; BCAA: branched chain amino acids; BCKA: branched chain ketoacids; MRI: magnetic resonance imaging; IVA: isovaleric acidemia; PPA: propionic acidemia; MMA: methylmalonic acidemia; GA1: glutaric acidemia I; PLP: pyridoxal phosphate; ALDH7A1: antiquitin gene; P6C: piperideine-6-carboxylic acid; 3-PGDH: 3-phosphoglyceric dehydrogenase; 3-PSP: 3-phosphoserine phosphatase; GAMT: guanidinacetate acid methyl transferase , OXPHOS: oxidative phosphorylation; PDHc: pyruvate dehydrogenase complex; SOD: superoxide dismutase; MOCO: molybdenum cofactor; ZS: Zellweger syndrome; NALD: neonatal adrenoleucodystrophy; RF: Refsum disease; GLD: globoid leucodystrophy.…”
Section: Overview Of Clinical Manifestationsmentioning
confidence: 99%
See 4 more Smart Citations
“…An IEM should be suspected in a neonate presenting with seizures, particularly if unexplained and refractory [6]. Moreover, several metabolic disorders present with specific epileptic encephalopathies associated to quite suggestive EEG patterns [8]. Early Myoclonic Encephalopathy (EME) is one of the most severe, drug-resistant epilepsy with poor prognosis Abbreviations NS : neonatal seizures; CNS: central nervous system; IEM: inborn errors of metabolism; EEG: electroencephalogram; EME: early myoclonic encephalopathy; NKH: non-ketotic hyperglycinaemia; HIE: hypoxic-ischemic encephalopathy; UCDs: urea cycle disorders; CPSI: carbamyl phosphate synthetase I; OTC: ornithine transcarbamylase; ASS: arginine succinic acid synthetase; ASL: arginine succinic acid lyase: ARG: arginase; BCAA: branched chain amino acids; BCKA: branched chain ketoacids; MRI: magnetic resonance imaging; IVA: isovaleric acidemia; PPA: propionic acidemia; MMA: methylmalonic acidemia; GA1: glutaric acidemia I; PLP: pyridoxal phosphate; ALDH7A1: antiquitin gene; P6C: piperideine-6-carboxylic acid; 3-PGDH: 3-phosphoglyceric dehydrogenase; 3-PSP: 3-phosphoserine phosphatase; GAMT: guanidinacetate acid methyl transferase , OXPHOS: oxidative phosphorylation; PDHc: pyruvate dehydrogenase complex; SOD: superoxide dismutase; MOCO: molybdenum cofactor; ZS: Zellweger syndrome; NALD: neonatal adrenoleucodystrophy; RF: Refsum disease; GLD: globoid leucodystrophy.…”
Section: Overview Of Clinical Manifestationsmentioning
confidence: 99%
“…Several IEMs may be associated to EME such as non-ketotic hyperglycinaemia (NKH), propionic or methylmalonic acidurias, methylene tetrahydrofolate reductase deficiency, GABA transaminase deficiency, serine deficiency, congenital glutamine deficiency, sulfite and xantine oxidase deficiency, and vitamin-responsive syndromes as pyridoxine, pyridoxal-phosphate, folinic and biotin deficiencies [2]. Other less specific types of seizures such as focal or generalised clonic, tonic and/or myoclonic ones may frequently occur [8].…”
Section: Overview Of Clinical Manifestationsmentioning
confidence: 99%
See 3 more Smart Citations